APOBEC1 and APOBEC3 Cytidine Deaminases as Restriction Factors for Hepadnaviral Genomes in Non-Humans In Vivo

Journal of Molecular Biology

Volumn 400, Issue 3, 2010, Pages 323-334

  Renard, Myrtille ^a   Henry, Michel ^a   Guétard, Denise ^a   Vartanian, Jean Pierre ^a   Wain Hobson, Simon ^a  

^a CNRS   (France)

Author keywords

APOBEC; Cytidine deaminase; HBV; Mouse; Restriction factor

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3; CYTIDINE DEAMINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEPADNAVIRUS INFECTION; HEPATITIS B VIRUS; HUMAN; IN VIVO STUDY; LIVER; LIVER CELL CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCANDENTIA; VIRUS GENOME; WOODCHUCK HEPATITIS VIRUS;

HEPADNAVIRIDAE; HEPATITIS B VIRUS; MAMMALIA; PLATYRRHINI; PRIMATES; TUPAIIDAE; WOODCHUCK HEPATITIS VIRUS;

EID: 77954385611     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.05.029     Document Type: Article

References (58)

1. Buseyne F., Le Gall S., Boccaccio C., Abastado J.P., Lifson J.D., Arthur L.O., et al. MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat. Med. 2001, 7:344-349.
2. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 2001, 14:778-809.
3. Uematsu S., Akira S. Toll-like receptors and Type I interferons. J. Biol. Chem. 2007, 282:15319-15323.
4. Huthoff H., Towers G.J. Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha. Trends Microbiol. 2008, 16:612-619.
5. Beale R.C., Petersen-Mahrt S.K., Watt I.N., Harris R.S., Rada C., Neuberger M.S. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo. J. Mol. Biol. 2004, 337:585-596.
6. Bishop K.N., Holmes R.K., Sheehy A.M., Davidson N.O., Cho S.J., Malim M.H. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 2004, 14:1392-1396.
7. Conticello S.G., Harris R.S., Neuberger M.S. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol. 2003, 13:2009-2013.
8. Lecossier D., Bouchonnet F., Clavel F., Hance A.J. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 2003, 300:1112.
9. Harris R.S., Liddament M.T. Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol. 2004, 4:868-877.
10. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003, 424:99-103.
11. Mariani R., Chen D., Schrofelbauer B., Navarro F., Konig R., Bollman B., et al. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 2003, 114:21-31.
12. Suspène R., Sommer P., Henry M., Ferris S., Guétard D., Pochet S., et al. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Res. 2004, 32:2421-2429.
13. Bogerd H.P., Doehle B.P., Wiegand H.L., Cullen B.R. A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc. Natl Acad. Sci. USA 2004, 101:3770-3774.
14. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003, 424:94-98.
15. Koning F.A., Newman E.N., Kim E.Y., Kunstman K.J., Wolinsky S.M., Malim M.H. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J. Virol. 2009, 83:9474-9485.
16. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002, 418:646-650.
17. Gifford R.J., Katzourakis A., Tristem M., Pybus O.G., Winters M., Shafer R.W. A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution. Proc. Natl Acad. Sci. USA 2008, 105:20362-20377.
18. Gilbert C., Maxfield D.G., Goodman S.M., Feschotte C. Parallel germline infiltration of a lentivirus in two Malagasy lemurs. PLoS Genet. 2009, 5:e1000425.
19. Katzourakis A., Tristem M., Pybus O.G., Gifford R.J. Discovery and analysis of the first endogenous lentivirus. Proc. Natl Acad. Sci. USA 2007, 104:6261-6265.
20. Vartanian J.P., Meyerhans A., Asjo B., Wain-Hobson S. Selection, recombination, and G→A hypermutation of human immunodeficiency virus type 1 genomes. J. Virol. 1991, 65:1779-1788.
21. Bonvin M., Achermann F., Greeve I., Stroka D., Keogh A., Inderbitzin D., et al. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 2006, 43:1364-1374.
22. Peng G., Lei K.J., Jin W., Greenwell-Wild T., Wahl S.M. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J. Exp. Med. 2006, 203:41-46.
23. Refsland, E. W., Stenglein, M. D., Shindo, K., Albin, J. S., Brown, W. L. & Harris, R. S. (2010). Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. In press. doi:10.1093/nar/gkq174.
24. Stenglein M.D., Burns M.B., Li M., Lengyel J., Harris R.S. APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat. Struct. Mol. Biol. 2010, 17:222-229.
25. Tanaka Y., Marusawa H., Seno H., Matsumoto Y., Ueda Y., Kodama Y., et al. Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes. Biochem. Biophys. Res. Commun. 2006, 341:314-319.
26. Wang F.X., Huang J., Zhang H., Ma X. APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells. J. Gen. Virol. 2008, 89:722-730.
27. Jarmuz A., Chester A., Bayliss J., Gisbourne J., Dunham I., Scott J., Navaratnam N. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 2002, 79:285-296.
28. Abe H., Ochi H., Maekawa T., Hatakeyama T., Tsuge M., Kitamura S., et al. Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection. Hepatol. Res. 2009, 39:1159-1168.
29. Noguchi C., Imamura M., Tsuge M., Hiraga N., Mori N., Miki D., et al. G-to-A hypermutation in hepatitis B virus (HBV) and clinical course of patients with chronic HBV infection. J. Infect. Dis. 2009, 199:1599-1607.
30. Vartanian J.P., Henry M., Marchio A., Suspène R., Aynaud M.M., Guétard D. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog 2010, 6:e1000928.
31. Conticello S.G., Thomas C.J., Petersen-Mahrt S.K., Neuberger M.S. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol. Biol. Evol. 2005, 22:367-377.
32. Henry M., Guétard D., Suspène R., Rusniok C., Wain-Hobson S., Vartanian J.P. Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G. PLoS ONE 2009, 4:e4277.
33. Langlois M.A., Beale R.C., Conticello S.G., Neuberger M.S. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities. Nucleic Acids Res. 2005, 33:1913-1923.
34. Suspène R., Guétard D., Henry M., Sommer P., Wain-Hobson S., Vartanian J.P. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc. Natl Acad. Sci. USA 2005, 102:8321-8326.
35. Chisari F.V. Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr. Top. Microbiol. Immunol. 1996, 206:149-173.
36. Guidotti L.G., Chisari F.V. Immunobiology and pathogenesis of viral hepatitis. Annu. Rev. Pathol. 2006, 1:23-61.
37. Larue R.S., Andresdottir V., Blanchard Y., Conticello S.G., Derse D., Emerman M., et al. Guidelines for naming non-primate APOBEC3 genes and proteins. J. Virol. 2008, 83:494-497.
38. Larue R.S., Jonsson S.R., Silverstein K.A., Lajoie M., Bertrand D., El-Mabrouk N., et al. The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. BMC Mol. Biol. 2008, 9:104.
39. Greeve J., Altkemper I., Dieterich J.H., Greten H., Windler E. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J. Lipid Res. 1993, 34:1367-1383.
40. Bremer C.M., Bung C., Kott N., Hardt M., Glebe D. Hepatitis B virus infection is dependent on cholesterol in the viral envelope. Cell. Microbiol. 2009, 11:249-260.
41. Glebe D., Aliakbari M., Krass P., Knoop E.V., Valerius K.P., Gerlich W.H. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J. Virol. 2003, 77:9511-9521.
42. Wieland S.F., Spangenberg H.C., Thimme R., Purcell R.H., Chisari F.V. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc. Natl Acad. Sci. USA 2004, 101:2129-2134.
43. Mason W.S., Aldrich C., Summers J., Taylor J.M. Asymmetric replication of duck hepatitis B virus DNA in liver cells: free minus-strand DNA. Proc. Natl Acad. Sci. USA 1982, 79:3997-4001.
44. Ogston C.W., Jonak G.J., Rogler C.E., Astrin S.M., Summers J. Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from hepatocellular carcinomas of woodchucks. Cell 1982, 29:385-394.
45. Petit V., Guétard D., Renard M., Keriel A., Sitbon M., Wain-Hobson S., Vartanian J.P. Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. J. Mol. Biol. 2009, 385:65-78.
46. Suspène R., Henry M., Guillot S., Wain-Hobson S., Vartanian J.P. Recovery of APOBEC3-edited human immunodeficiency virus G→A hypermutants by differential DNA denaturation PCR. J. Gen. Virol. 2005, 86:125-129.
47. Pasquetto V., Wieland S.F., Uprichard S.L., Tripodi M., Chisari F.V. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J. Virol. 2002, 76:5646-5653.
48. Guidotti L.G., Rochford R., Chung J., Shapiro M., Purcell R., Chisari F.V. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999, 284:825-829.
49. Turelli P., Liagre-Quazzola A., Mangeat B., Verp S., Jost S., Trono D. APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. J. Virol. 2008, 82:6585-6590.
50. Raney A.K., Eggers C.M., Kline E.F., Guidotti L.G., Pontoglio M., Yaniv M., McLachlan A. Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice. J. Virol. 2001, 75:2900-2911.
51. Bishop K.N., Holmes R.K., Malim M.H. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J. Virol. 2006, 80:8450-8458.
52. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigo R., Gingeras T.R., Margulies E.H., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447:799-816.
53. Nguyen D.H., Gummuluru S., Hu J. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G. J. Virol. 2007, 81:4465-4472.
54. Wieland S.F., Chisari F.V. Stealth and cunning: hepatitis B and hepatitis C viruses. J. Virol. 2005, 79:9369-9380.
55. Bishop K.N., Verma M., Kim E.Y., Wolinsky S.M., Malim M.H. APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog. 2008, 4:e1000231.
56. Scaglioni P.P., Melegari M., Wands J.R. Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J. Virol. 1997, 71:345-353.
57. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 1997, 25:4876-4882.
58. Felsenstein J. Mathematics vs. evolution: mathematical evolutionary theory. Science 1989, 246:941-942.